Rating History for CytoMed Therapeutics (GDTC) by Benchmark

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
7/21/2023 Bruce Jackson New Coverage Speculative Buy
(N/A)
5.00
(N/A)
3.85
(1.05)
-72.73% Details